why choose us

Clinical Trials Search

Showing 7,100 of 132,085 result(s)
The Effects of CSE and ISE on Pain, Strength, Flexibility, Disability and QoL in Patients With CDH

Status: Completed

Condition: Cervical Disc Herniation

Interventions: Segmental spine stabilization exercises were composed of axial extension, cervical extension exercises, cervico-scapulothoracic strengthening and cran

Date: 2023-10-18

Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

Status: Completed

Condition: Idiopathic Pulmonary Fibrosis

Interventions: PLN-74809

Date: 2023-10-18

Penetrating Trauma Registry and Open Source Data

Status: Completed

Condition: Penetrating Trauma Registry and Open Source Data

Interventions: To conduct observational process improvement and hypothesis-deriving studies related to penetrating traumatic injuries using data from the Methodist t

Date: 2023-10-18

A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and;or Palms of the Hands and the Soles of the Feet)

Status: Completed

Condition: Plaque Psoriasis

Interventions: JNJ-77242113 will be administered orally.

Date: 2023-10-18

Home-Based Respiratory Muscle Strength Training Program for Individuals With Post-COVID-19 Persistent Dyspnea

Status: NOT_YET_RECRUITING

Condition: Post-COVID-19 Syndrome

Interventions: Devices provided to each participant.
Resistance loading set at less than 50% of the peak inspiratory and peak expiratory flow rate.

Date: 2023-10-18

Beacon Sensors and Telerehabilitation to Assess and Improve Use of Devices (BeST-AID) for Low Vision

Status: Completed

Condition: Low Vision

Interventions: Evaluation and training with magnification or visual assistive devices for visually-impaired adults

Date: 2023-10-18

Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes

Status: Completed

Condition: Type 2 Diabetes

Interventions: Ketones are a nutritional supplement currently used by athletes for their performance enhancing effects - specifically their cardio-pulmonary benefits

Date: 2023-10-18

A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus

Status: Completed

Condition: Respiratory Syncytial Virus

Interventions: Sterile liquid for injection

Date: 2023-10-18

Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS

Status: NOT_YET_RECRUITING

Condition: Advanced Solid Tumors

Interventions: YL-17231 will be administered orally once daily in a continuous regimen

Date: 2023-10-18